AI Transforming Drug Discovery: Next Biotech Boom Ahead
Artificial intelligence is turbocharging drug discovery, cutting years from development timelines and sparking a surg...
We explain how crypto assets resemble tokens and coins, highlighting differences in functionality, value, and governance.
28,655 articlesArtificial intelligence is turbocharging drug discovery, cutting years from development timelines and sparking a surg...
The U.S. national debt has topped $39 trillion as of March 2026, propelled by ongoing deficits and higher interest co...
Cerebras signals an upcoming IPO as it presses to outpace Nvidia and rival AI-chip startups in the fast-moving genera...
NVIDIA delivered blockbuster AI-focused results that strengthen a nvidia buy thesis, while Palantir faces valuation h...
Fans are feeling the pinch as prices rise for both stadium seats and bar stools. A new survey shows a growing split i...
As HMBS 2.0 stalls and a 98% buyout rule tightens liquidity, Longbridge Financial’s Tim Wilkinson explains how privat...
Samsung outperformed Nvidia on operating profit in the latest quarter, even as market jitters hit the chip sector. Ji...
IBM and Oracle have quietly strengthened AI backlogs and earnings, setting up a potential late-2026 surprise as marke...
Unilever is betting big on the 2026 World Cup, weaving social, digital and in-store campaigns to turn fans into loyal...
In a hypothetical shift at the Federal Reserve, kevin warsh leading fed would test how the central bank tames inflati...
Earnings beats aren’t enough to steady markets as stocks see bigger, more persistent swings. The article explains wha...
A Texas primary shock sends markets into a risk-off mode as sen. john cornyn becomes a flashpoint for party fault lin...